Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Program effective Date: May 01, 2026
Search Results
Displaying 4181 - 4190 of 4294 results
Provider
Vtama (tapinarof) - Commercial
Prior Authorization
Program effective Date: May 01, 2026
Provider
PCSK9 Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Selective Serotonin Inverse Agonist (SSIA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Hetlioz (tasimelteon) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026
Provider
Atypical Antipsychotics - Commercial
Step Therapy, Quantity Limit
Program effective Date: May 01, 2026
Provider
Atypical Antipsychotics - Extended Maintenance Agents - Commercial
Step Therapy, Quantity Limit
Program effective Date: May 01, 2026
Provider
Antidepressant Agents - Commercial
Step Therapy, Quantity Limit
Program effective Date: May 01, 2026
Provider
Vtama (tapinarof) - Medicaid
Prior Authorization
Program effective Date: May 01, 2026
Provider
Zeposia (ozanimod) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2026